Lumira Ventures
Life sciences venture capital firm investing in biotechnology and medical device companies from early to late stage across North America
Secteur: Life Sciences
Sofinnova Partners
Pan-European fund creating and building entrepreneur-driven companies in biotechnology and medical devices
TVM Capital
Early stage fund focused on life sciences companies with a project-based approach in partnership with Eli Lilly as well as traditional later-stage companies, including an allocation for diagnostic companies in partnership with Qiagen
Versant Ventures
Californian venture firm operating incubators in Canada and investing through self-sustaining drug development units
Versant Ventures Vantage
Late-stage opportunity fund investing in prior Versant Ventures fund companies
Versant Ventures Voyageurs
Canada-focused fund investing alongside Versant Ventures’ primary biotech funds and targeting seed, de novo and early-stage Canadian biotechnology companies
Fusion Pharmaceuticals
Clinical stage bio-pharmaceutical company focused on developing alpha therapeutics for curing cancer
Northern Biologics
Northern Biologics’ mission is to develop first-in-class antibody therapeutics for oncology
Repare Therapeutics
Clinical stage company developing therapeutics targeting DNA repair proteins for the treatment of cancer
Turnstone Biologics
Turnstone Biologics’ mission is to deliver breakthrough viral immunotherapies to improve survival for patients with cancer